{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T06:57:35Z","timestamp":1648882655932},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.diagmicrobio.2009.01.019","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T06:13:19Z","timestamp":1237356799000},"page":"440-446","source":"Crossref","is-referenced-by-count":10,"title":["Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003\u20132007)"],"prefix":"10.1016","volume":"63","author":[{"given":"Thomas R.","family":"Fritsche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Stillwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: a review of its use in the treatment of serious bacterial infections","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.01114-07","article-title":"Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase\u2013producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program","volume":"52","author":"Castanheira","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/CCM.0b013e3181691b99","article-title":"Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study","volume":"36","author":"Chastre","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib4","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/AAC.49.6.2510-2511.2005","article-title":"In vitro activity of doripenem (S-4661) against multidrug-resistant gram-negative bacilli isolated from patients with cystic fibrosis","volume":"49","author":"Chen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib5","series-title":"Methods of dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u2014seventh edition, M7-A7","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib6","series-title":"Performance standards for antimicrobial susceptibility testing, 18th informational supplement, M100-S18","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/jac\/dkn004","article-title":"Activity of doripenem and comparator beta-lactams against US clinical isolates of Streptococcus pneumoniae with defined mutations in the penicillin binding domains of pbp1a, pbp2b and pbp2x","volume":"61","author":"Davies","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1469-0691.2005.01271.x","article-title":"Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003)","volume":"11","author":"Fritsche","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/AAC.48.4.1384-1396.2004","article-title":"In vitro antimicrobial activity of doripenem, a new carbapenem","volume":"48","author":"Ge","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1128\/AAC.01128-07","article-title":"In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds","volume":"52","author":"Goldstein","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/08998280.2008.11928422","article-title":"Doripenem (Doribax): the newest addition to the carbapenems","volume":"21","author":"Greer","year":"2008","journal-title":"Proc. (Bayl. Univ. Med. Cent)."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib13","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.48.8.3136-3140.2004","article-title":"Activities of doripenem (S-4661) against drug-resistant clinical pathogens","volume":"48","author":"Jones","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/jac\/dkh298","article-title":"Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations","volume":"54","author":"Jones","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diagmicrobio.2004.12.008","article-title":"Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms","volume":"52","author":"Jones","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2004.07.003","article-title":"Emerging epidemic of metallo-beta-lactamase\u2013mediated resistances","volume":"51","author":"Jones","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib17","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2165\/00003495-200868140-00007","article-title":"Doripenem: a review of its use in the treatment of bacterial infections","volume":"68","author":"Keam","year":"2008","journal-title":"Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2009.01.019_bib18","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/590061","article-title":"Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front","volume":"47","author":"Kollef","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jac\/dkm129","article-title":"Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY","volume":"60","author":"Landman","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/14787210.5.5.793","article-title":"Carbapenems in the USA: focus on doripenem","volume":"5","author":"Lister","year":"2007","journal-title":"Expert Rev. Anti. Infect. Ther."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tim.2006.07.008","article-title":"The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter","volume":"14","author":"Livermore","year":"2006","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.clinthera.2008.04.019","article-title":"Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study","volume":"30","author":"Lucasti","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib23","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/AAC.48.8.3086-3092.2004","article-title":"Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential","volume":"48","author":"Mushtaq","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1128\/AAC.48.4.1313-1319.2004","article-title":"Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases","volume":"48","author":"Mushtaq","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.9.1.23","article-title":"Carbapenems: a potent class of antibiotics","volume":"9","author":"Nicolau","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib26","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1128\/AAC.00381-08","article-title":"In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States","volume":"52","author":"Pillar","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.diagmicrobio.2007.05.009","article-title":"Activity of meropenem as serine carbapenemases evolve in US Medical Centers: monitoring report from the MYSTIC Program (2006)","volume":"59","author":"Rhomberg","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2009.01.019_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1469-0691.2007.01868.x","article-title":"Parenteral carbapenems","volume":"14","author":"Shah","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib29","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1128\/AAC.00696-08","article-title":"In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group","volume":"52","author":"Snydman","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.50.2.819-821.2006","article-title":"In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients","volume":"50","author":"Traczewski","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.01.019_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dkm226","article-title":"Class A carbapenemases","volume":"60","author":"Walther-Rasmussen","year":"2007","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T18:12:08Z","timestamp":1558203128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889309000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0732889309000248"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.01.019","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}